AMRX - Amneal Pharmaceuticals, Inc.
13.02
-0.240 -1.843%
Share volume: 1,048,886
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.24
-0.02%
Summary score
59%
Profitability
58%
Dept financing
43%
Liquidity
68%
Performance
61%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
3.03%
Return on sales
13.76%
Return on invested capital
0%
Total debt ratio
101.92%
Debt ratio change over timeo
0%
Current Ratio
2.17%
Quick Ratio
1.48%
Cash Position Ratio
0.32%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
3.03%
Return on sales
13.76%
Return on invested capital
0%
Total debt ratio
101.92%
Debt ratio change over timeo
0%
Current Ratio
2.17%
Quick Ratio
1.48%
Cash Position Ratio
0.32%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
3.03%
Return on sales
13.76%
Return on invested capital
0%
Total debt ratio
101.92%
Debt ratio change over time
0%
Current Ratio
2.17%
Quick Ratio
1.48%
Cash Position Ratio
0.32%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | 3.03% | 4.74% | 3.19% | 1.73% |
| Return on sales | 13.76% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 27% | 93% | 84% | 29% |
| Total debt ratio | 101.92% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 17.33% |
| Dept financing | 25% | 20% | 15% | 48% |
| Current Ratio | 2.17% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 1.48% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.32% | 0.16% | 0.44% | 0.14% |
| Liquididy | 66% | 38% | 54% | 34% |
| Short-term ratios | AMRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 3.03% | 6.06% | 4.18% | 1.7% |
| Return on sales | 13.76% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 71% | 50% | 34% | 23% |
| Total debt ratio | 101.92% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 20% | 15% | 25% |
| Current Ratio | 2.17% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 1.48% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.32% | 0.16% | 0.44% | 0.14% |
| Liquididy | 68% | 45% | 52% | 26% |